An Update on Hepatitis B Virus Infection
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource from the RWHAP Best Practices Compilation updated on 02/12/2024
Resource from the RWHAP Best Practices Compilation updated on 01/03/2024
Resource from the RWHAP Best Practices Compilation updated on 11/26/2023
Resource from the RWHAP Best Practices Compilation updated on 02/12/2024
Resource from the RWHAP Best Practices Compilation updated on 01/07/2024
Barriers and facilitators to HCV treatment during the DAA era for the understudied and high-risk population of HIV/HCV co-infected patients who delay or do not consent to treatment, and interventions for increasing DAA treatment uptake.
Resource (Conference Presentation) updated 09/14/2023
Overview of the policies, procedures, and protocols developed by an ADAP and Part C clinic to establish access to antiretrovirals, including long-acting cabotegravir/rilpivirine.
Resource (Conference Presentation) updated 09/14/2023
Resource from the RWHAP Best Practices Compilation updated on 11/30/2023
Resource from the RWHAP Best Practices Compilation updated on 02/28/2024
RWHAP Technical Assistance Provider updated on 05/24/2024
Resource from the RWHAP Best Practices Compilation updated on 11/27/2023
Resource from the RWHAP Best Practices Compilation updated on 01/09/2024
Resource updated 10/13/2023
Resource updated 10/13/2023
Resource from the RWHAP Best Practices Compilation updated on 04/15/2024
RWHAP Technical Assistance Provider updated on 05/15/2024